We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$2.93T
AUM Growth
+$236B
Cap. Flow
+$19B
Cap. Flow %
0.65%
Top 10 Hldgs %
16.4%
Holding
4,214
New
61
Increased
2,384
Reduced
1,277
Closed
87

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.46B
2
TFC icon
Truist Financial
TFC
+$2.5B
3
BABA icon
Alibaba
BABA
+$2.04B
4
UBER icon
Uber
UBER
+$1.04B
5
NOW icon
ServiceNow
NOW
+$937M

Sector Composition

Rank Sector Weight
1 Technology 18.84%
2 Financials 15%
3 Healthcare 13.05%
4 Consumer Discretionary 9.93%
5 Industrials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDR
2351
DELISTED
Cedar Realty Trust, Inc
CDR
$29.1M ﹤0.01%
1,493,920
+59,942
+4% +$1.16M
APHA
2352
DELISTED
Aphria Inc. Common Shares
APHA
$29.1M ﹤0.01%
5,567,466
+37,106
+0.7% +$182K
WTTR icon
2353
Select Water Solutions
WTTR
$2.61B
$29M ﹤0.01%
3,128,886
+33,137
+1% +$268K
PGNX
2354
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$29M ﹤0.01%
5,703,951
+50,590
+0.9% +$268K
VVX icon
2355
V2X
VVX
$2.65B
$29M ﹤0.01%
566,125
-42,636
-7% -$2.06M
CNXN icon
2356
PC Connection
CNXN
$2.12B
$28.8M ﹤0.01%
580,066
-6,183
-1% -$287K
CCRN
2357
DELISTED
Cross Country Healthcare
CCRN
$28.8M ﹤0.01%
2,477,057
+25,619
+1% +$289K
SHOE
2358
Shoe Station Group
SHOE
$428M
$28.7M ﹤0.01%
1,541,848
-28,994
-2% -$513K
REVG
2359
DELISTED
REV Group
REVG
$28.7M ﹤0.01%
2,347,360
+4,053
+0.2% +$51.3K
SHYF
2360
DELISTED
The Shyft Group
SHYF
$28.7M ﹤0.01%
1,585,749
-19,582
-1% -$327K
FRO icon
2361
Frontline
FRO
$8.85B
$28.6M ﹤0.01%
2,226,433
+18,629
+0.8% +$203K
LX
2362
LexinFintech Holdings
LX
$241M
$28.6M ﹤0.01%
2,059,022
+154,868
+8% +$1.78M
RRGB icon
2363
Red Robin
RRGB
$152M
$28.5M ﹤0.01%
861,878
-697
-0.1% -$20.6K
TPIC
2364
DELISTED
TPI Composites
TPIC
$28.5M ﹤0.01%
1,537,212
+105,305
+7% +$1.93M
RPT
2365
Rithm Property Trust
RPT
$93.7M
$28.4M ﹤0.01%
331,367
+136,814
+70% +$12.1M
RUBY
2366
DELISTED
Rubius Therapeutics, Inc
RUBY
$28.4M ﹤0.01%
2,988,657
+84,826
+3% +$821K
LOCO icon
2367
El Pollo Loco
LOCO
$462M
$28.2M ﹤0.01%
1,864,587
-427,873
-19% -$5.98M
MBWM icon
2368
Mercantile Bank Corp
MBWM
$1.05B
$28.2M ﹤0.01%
772,742
+11,724
+2% +$412K
PGNY icon
2369
Progyny
PGNY
$2.2B
$28.1M ﹤0.01%
+1,022,650
New +$24.5M
BCRX icon
2370
BioCryst Pharmaceuticals
BCRX
$2.4B
$28M ﹤0.01%
8,121,631
+2,142,710
+36% +$5.39M
FLIC
2371
DELISTED
First of Long Island Corp
FLIC
$28M ﹤0.01%
1,116,979
-7,194
-0.6% -$172K
QCRH icon
2372
QCR Holdings
QCRH
$1.7B
$28M ﹤0.01%
637,989
+50,275
+9% +$2.05M
GSAT icon
2373
Globalstar
GSAT
$10.8B
$27.9M ﹤0.01%
3,590,236
+109,072
+3% +$659K
POWL icon
2374
Powell Industries
POWL
$7.71B
$27.9M ﹤0.01%
1,706,808
-132,348
-7% -$1.86M
DCO icon
2375
Ducommun
DCO
$2.98B
$27.9M ﹤0.01%
551,323
+2,645
+0.5% +$122K

Similar funds

Vanguard Group's Q4 2019 Portfolio in Review

As of Q4 2019, Vanguard Group held 4,214 positions worth $2.93T, up 8.7% from $2.7T the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.5%. Vanguard Group opened 61 new positions and exited 87, leaving the 4,214-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Vanguard Group's largest Q4 2019 buy was Broadmark Realty Capital Inc. Common Stock: 8,851,056 shares worth $113M.
  • Vanguard Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.46B increase.
  • Vanguard Group's biggest Q4 2019 reduction was Global Payments, cutting an estimated $641M.
  • Vanguard Group fully exited Celgene Corp in Q4 2019, selling an estimated $5.45B.
  • Vanguard Group's ten largest holdings make up 16% of its $2.93T portfolio in Q4 2019.
  • Vanguard Group opened 61 new positions and closed 87 in Q4 2019.
  • Vanguard Group's portfolio value rose 8.7% quarter-over-quarter to $2.93T.

Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.